Article

Identifying biomarkers of anti-cancer drug synergy using multi-task learning

2018-01-05

Abstract excerpt

Combining anti-cancer drugs has the potential to increase treatment efficacy. Because patient responses to drug combinations are highly variable, predictive biomarkers of synergy are required to identify which patients are likely to benefit from a drug combination. To aid biomarker identification, the DREAM challenge consortium has recently released data from a screen containing 85 cell lines and 167 drug combinat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fcf19167-5650-53b7-ba61-0f2193362506
DOI: 10.1101/243568

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identifying biomarkers of anti-cancer drug synergy using multi-task learningDOI 10.1101/243568Read

Linking drug target and pathway activation for effective therapy using multi-task learningSemantic proximity Read

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in CancerSemantic proximity Read

A systematic evaluation of deep learning methods for the prediction of drug synergy in cancerSemantic proximity Read

SynPred: Prediction of Drug Combination Effects in Cancer using Full-Agreement Synergy Metrics and Deep LearningSemantic proximity Read

Pisces: A multi-modal data augmentation approach for drug combination synergy predictionSemantic proximity Read

Explainable machine learning prediction of synergistic drug combinations for precision cancer medicineSemantic proximity Read

TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types.Semantic proximity Read

SynVerse: A Framework for Systematic Evaluation of Deep Learning Based Drug Synergy Prediction ModelsSemantic proximity Read

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapiesSemantic proximity Read

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to DiscoverySemantic proximity Read

Joint Prediction of Adjuvant Therapy Response and Time-to-Response for Cancer Patients Using the Personalized-DrugRank MethodSemantic proximity Read

SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug DesignSemantic proximity Read